EVAX Should I Buy

EVAX is not a good buy right now for a beginner long-term investor with $50k–$100k. The stock is in a sharp downtrend with weakening momentum (bearish MACD expansion) and micro-cap biotech risk, and there are no strong proprietary buy signals or near-term positive catalysts to justify entering immediately. If you already own it, this setup leans more toward “wait/avoid adding” than “buy now.”

Price/Trend: EVAX closed at 3.613 after a large -11.47% regular-session drop, indicating strong bearish pressure. Momentum: MACD histogram is -0.105 and negatively expanding → downside momentum is still increasing. RSI: RSI(6) = 17.184 → deeply oversold, which can lead to short bounces, but oversold alone is not a reliable long-term entry signal when MACD keeps deteriorating. Moving Averages: Converging MAs suggests a transition zone, but not a confirmed uptrend. Levels: Pivot 4.342 (well above current price). Support S1 3.719 (price is below it, which is bearish); next support S2 3.334. Resistance R1 4.964. Pattern-based probabilistic trend (provided): modest near-term upside odds, but next-month expectation is slightly negative (-0.42%), aligning with weak momentum. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.